Free Trial
NASDAQ:GDRX

GoodRx Q1 2026 Earnings Report

GoodRx logo
$2.57 +0.01 (+0.39%)
Closing price 05/6/2026 04:00 PM Eastern
Extended Trading
$2.57 +0.00 (+0.04%)
As of 07:53 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Live Event
Earnings Conference Call
GoodRx Q1 2026
00:00 / 00:00
Live Transcript
Follow Audio

GoodRx EPS Results

Actual EPS
$0.07
Consensus EPS
$0.07
Beat/Miss
Met Expectations
One Year Ago EPS
$0.09

GoodRx Revenue Results

Actual Revenue
$194.01 million
Expected Revenue
$185.42 million
Beat/Miss
Beat by +$8.59 million
YoY Revenue Growth
-4.40%

GoodRx Announcement Details

Quarter
Q1 2026
Time
After Market Closes
Conference Call Date
Thursday, May 7, 2026
Conference Call Time
8:00AM ET

GoodRx Earnings Headlines

GoodRx (NASDAQ:GDRX) Beats Q1 CY2026 Sales Expectations
GoodRx Reports First Quarter 2026 Results
I was right about SpaceX
Jeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,000%. Now he says SpaceX is shaping up to be the biggest IPO of the decade - and three key milestones just confirmed it. In the past 21 days: SpaceX crossed 10,000 active satellites, Elon filed confidential IPO paperwork with the SEC, and another rocket launched 25 more satellites. Two-thirds of every satellite in orbit now belongs to one company. The public filing could drop any day.tc pixel
GoodRx Names Thomas Chan Chief Accounting Officer
See More GoodRx Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like GoodRx? Sign up for Earnings360's daily newsletter to receive timely earnings updates on GoodRx and other key companies, straight to your email.

About GoodRx

GoodRx (NASDAQ:GDRX) (NASDAQ: GDRX) operates a digital healthcare platform designed to help consumers compare prescription drug prices at retail pharmacies across the United States. Through its website and mobile applications, GoodRx aggregates pricing and discount information from a wide network of pharmacies, enabling users to access coupons and savings programs on both generic and brand-name medications. The platform also features price transparency tools that inform patients about cost variations and available discounts to alleviate the financial burden of prescription medications.

In addition to its core drug pricing service, GoodRx offers telehealth services under the GoodRx Care brand, providing virtual consultations for a range of non-emergency conditions and prescription needs. Users can connect with licensed healthcare professionals online for diagnostics and treatment, with the option to have prescriptions delivered to their home or sent to a local pharmacy. GoodRx also markets GoodRx Gold, a membership program that further reduces out-of­-pocket costs for prescription drugs, as well as GoodRx Shop, an e-commerce marketplace for health and wellness products.

Founded in 2011, GoodRx is headquartered in Santa Monica, California, and focuses its operations on the U.S. market. The company went public in 2020, listing its shares on the Nasdaq exchange. Over the years, GoodRx has expanded its partnerships with pharmacy benefit managers, major retail pharmacy chains, and pharmaceutical manufacturers to broaden its discount offerings and enhance access to affordable medications for millions of Americans.

GoodRx’s leadership team includes co-founder Doug Hirsch, who serves as Executive Chairman, and Trevor Bezdek, who holds the role of Chief Executive Officer. Under their guidance, the company has pursued strategic acquisitions and product innovations aimed at simplifying healthcare navigation, improving price transparency and expanding virtual care services. GoodRx continues to evolve its platform to address the changing needs of consumers, healthcare providers and pharmacy partners nationwide.

View GoodRx Profile